Linde AG Acquires Lincare (LNCR) for $41.50/Share
Tweet Send to a FriendGet Alerts LNCR Hot Sheet
Price: $41.49 --0%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 1.9%
Revenue Growth %: +10.5%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 1.9%
Revenue Growth %: +10.5%
Trade LNCR Now!
Linde AG agrees to acquire Lincare Holdings Inc. (Nasdaq: LNCR) for $41.50 per share, or $4.6 billion.
The Lincare Board of Directors has unanimously approved the transaction. The price of USD 41.50 represents a premium of 64% over Lincare's share price of USD $25.26 on June 26, 2012 (the last day prior to press reports speculating as to Lincare's auction process), and also represents a premium of 49% over the three month volume weighted average price per Lincare share.
Completion of the offer is subject to customary conditions, including the expiration of the waiting period provided by U.S. antitrust laws and the tender of at least a majority of Lincare's outstanding shares of common stock. Closing is expected for the third quarter of 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Lincare Board of Directors has unanimously approved the transaction. The price of USD 41.50 represents a premium of 64% over Lincare's share price of USD $25.26 on June 26, 2012 (the last day prior to press reports speculating as to Lincare's auction process), and also represents a premium of 49% over the three month volume weighted average price per Lincare share.
Completion of the offer is subject to customary conditions, including the expiration of the waiting period provided by U.S. antitrust laws and the tender of at least a majority of Lincare's outstanding shares of common stock. Closing is expected for the third quarter of 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- Sears' (SHLD) Lampert: We'd Consider Other Asset Sales
- KKR & Co. Might Push for Neiman Marcus, Saks (SKS) Merger
Create E-mail Alert Related Categories
Hot M&A, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
